Citadel Advisors’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-19,610
| Closed | -$87.1K | – | 15807 |
|
|
2025
Q1 | $87.1K | Buy |
+19,610
| New | +$84.1K | ﹤0.01% | 11663 |
|
|
2024
Q3 | – | Sell |
-12,160
| Closed | -$45K | – | 15693 |
|
|
2024
Q2 | $45K | Buy |
+12,160
| New | +$48.5K | ﹤0.01% | 11882 |
|
|
2023
Q4 | – | Sell |
-3,515
| Closed | -$20K | – | 15518 |
|
|
2023
Q3 | $20K | Buy |
+3,515
| New | +$22.8K | ﹤0.01% | 12630 |
|
|
2022
Q4 | – | Sell |
-4,337
| Closed | -$97K | – | 15626 |
|
|
2022
Q3 | $97K | Buy |
4,337
+1,331
| +44% | +$36.5K | ﹤0.01% | 11124 |
|
|
2022
Q2 | $88K | Buy |
+3,006
| New | +$89.7K | ﹤0.01% | 11526 |
|
|
2021
Q3 | – | Sell |
-3,598
| Closed | -$98K | – | 14883 |
|
|
2021
Q2 | $98K | Buy |
3,598
+1,913
| +114% | +$49.1K | ﹤0.01% | 12937 |
|
|
2021
Q1 | $46K | Buy |
1,685
+11
| +0.7% | +$334 | ﹤0.01% | 12937 |
|
|
2020
Q4 | $42K | Buy |
+1,674
| New | +$27.5K | ﹤0.01% | 10631 |
|
|
2019
Q2 | – | Sell |
-363
| Closed | -$32K | – | 10015 |
|
|
2019
Q1 | $32K | Buy |
363
+110
| +43% | +$9.12K | ﹤0.01% | 8979 |
|
|
2018
Q4 | $15K | Buy |
+253
| New | +$21.1K | ﹤0.01% | 8844 |
|
|
2018
Q3 | – | Sell |
-189
| Closed | -$20K | – | 9821 |
|
|
2018
Q2 | $20K | Sell |
189
-78
| -29% | -$8.59K | ﹤0.01% | 8654 |
|
|
2018
Q1 | $30K | Buy |
+267
| New | +$33.5K | ﹤0.01% | 8056 |
|
|
2016
Q3 | – | Sell |
-40
| Closed | -$43K | – | 7905 |
|
|
2016
Q2 | $43K | Buy |
+40
| New | +$45.5K | ﹤0.01% | 6442 |
|
|
2015
Q3 | – | Sell |
-5
| Closed | -$11K | – | 9313 |
|
|
2015
Q2 | $11K | Hold |
5
| – | – | ﹤0.01% | 8386 |
|
|
2015
Q1 | $20K | Buy |
+5
| New | +$22K | ﹤0.01% | 7911 |
|
|
2014
Q2 | – | Sell |
-4
| Closed | -$24K | – | 8386 |
|
|
2014
Q1 | $24K | Buy |
+4
| New | +$25.8K | ﹤0.01% | 7213 |
|
|
2013
Q4 | – | Sell |
-4
| Closed | -$19K | – | 7204 |
|
|
2013
Q3 | $19K | Buy |
+4
| New | +$17.7K | ﹤0.01% | 6240 |
|
Citadel Advisors's NURO Position: Q2 2025 in Review
Citadel Advisors sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q2 2025, closing a stake of 19,610 shares — an estimated $87.1K sold.
Citadel Advisors first reported a position in NURO in Q3 2013 and held it in 17 quarters. The position peaked at $98K in Q2 2021. 0 funds tracked by Wall St. Rank hold NURO as of Q2 2025.
- Citadel Advisors reported no remaining NeuroMetrix, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
- Citadel Advisors sold 19,610 NeuroMetrix, Inc. Common Stock shares in Q2 2025, an estimated $87.1K.
- Citadel Advisors first reported a position in NeuroMetrix, Inc. Common Stock in Q3 2013 and held it in 17 quarters.
- Citadel Advisors's NeuroMetrix, Inc. Common Stock position peaked at $98K in Q2 2021.
- 0 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q2 2025.
Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.